Double Bond Pharmaceutical International
0.11 SEK
+2.33 %
Less than 1K followers
DBP B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Double Bond Pharmaceutical International
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 2.29 | 2.14 | 0.79 | 0.52 | 0.72 | 0.38 | 0.12 |
| Shares | 31.4 | 52.9 | 66.4 | 76.0 | 95.8 | 107.7 | 205.8 |
| Market cap | 71.9 | 113.5 | 52.5 | 39.9 | 69.2 | 40.4 | 24.5 |
| Enterprise value | 66.7 | 98.1 | 39.8 | 37.4 | 65.4 | 36.5 | - |
| EV/S | 276.6 | 84.7 | 41.7 | 30.2 | 47.8 | 33.5 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/B | 10.46 | 6.56 | 2.20 | 3.30 | 12.92 | -18.96 | 1.72 |
| P/S | 298.3 | 97.9 | 54.9 | 32.1 | 50.5 | 37.0 | 290.7 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 76.6 % | 75.9 % | 86.0 % | 78.4 % | 46.2 % | -34.2 % | 85.2 % |
| Gearing ratio | - | - | - | - | - | - | - |